Cargando…

Willingness-to-Pay and Benefit–Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China

BACKGROUND: Intense pulsed light (IPL), as a therapeutic approach for rosacea, had advantage in removing erythema and telangiectasia and was gradually accepted by rosacea patients, but there have been few studies on economic evaluation of this therapy. PURPOSE: This study aimed to detect willingness...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Qing, Zhang, Shu-ping, Deng, Yu-Xuan, Liu, Fang-fen, Shi, Wei, Xie, Hong-fu, Xiao, Yi, Huang, Ying-Xue, Li, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553264/
https://www.ncbi.nlm.nih.gov/pubmed/33116428
http://dx.doi.org/10.2147/PPA.S271859
_version_ 1783593563799420928
author Deng, Qing
Zhang, Shu-ping
Deng, Yu-Xuan
Liu, Fang-fen
Shi, Wei
Xie, Hong-fu
Xiao, Yi
Huang, Ying-Xue
Li, Ji
author_facet Deng, Qing
Zhang, Shu-ping
Deng, Yu-Xuan
Liu, Fang-fen
Shi, Wei
Xie, Hong-fu
Xiao, Yi
Huang, Ying-Xue
Li, Ji
author_sort Deng, Qing
collection PubMed
description BACKGROUND: Intense pulsed light (IPL), as a therapeutic approach for rosacea, had advantage in removing erythema and telangiectasia and was gradually accepted by rosacea patients, but there have been few studies on economic evaluation of this therapy. PURPOSE: This study aimed to detect willingness-to-pay (WTP) of IPL treatment for rosacea and to conduct a benefit–cost analysis (BCA) among the Chinese population, so as to provide an economic reference for doctors to make treatment decisions. MATERIALS AND METHODS: An observational, cross-sectional study assessed respondent’s demographic characteristics and willingness-to-pay (WTP) of IPL and rosacea patients’ clinical data and Dermatology Life Quality Index (DLQI). WTP was obtained by contingent valuation (CV) method. In brief, contrast figures of three cases treated with IPL (Case1, Case2, and Case3 represented the increasing severity of rosacea) were showed and WTP was inquired. The costs were obtained according the market and compared with WTP (benefits) to get a benefit–cost ratio (BCR). Predictors of cost-effective WTP were identified using the multivariable logistic regression model. RESULTS: A total of 303 rosacea patients and 202 controls were included in the study. The average cost of a single IPL treatment for rosacea was USD 208.04 in Changsha, China. The mean WTP for Case 1, Case 2, and Case 3 was USD 201.57, 214.64, and 221.74, respectively. WTP was statistically lower for Case 1 than that for Case 2 or Case 3 (P<0.05). The BCRs were 0.85, 1.03, and 1.06 for Case 1, Case 2, and Case 3, respectively. WTP is significantly associated with household monthly income, previous treatment cost, and DLQI after adjustments for demographic characteristics (P<0.05). CONCLUSION: IPL is an acceptable treatment for rosacea with moderate to severe erythema. For patients with relatively high income or severely impaired quality of life, IPL is an economically feasible therapy and deserves to be recommended.
format Online
Article
Text
id pubmed-7553264
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75532642020-10-27 Willingness-to-Pay and Benefit–Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China Deng, Qing Zhang, Shu-ping Deng, Yu-Xuan Liu, Fang-fen Shi, Wei Xie, Hong-fu Xiao, Yi Huang, Ying-Xue Li, Ji Patient Prefer Adherence Original Research BACKGROUND: Intense pulsed light (IPL), as a therapeutic approach for rosacea, had advantage in removing erythema and telangiectasia and was gradually accepted by rosacea patients, but there have been few studies on economic evaluation of this therapy. PURPOSE: This study aimed to detect willingness-to-pay (WTP) of IPL treatment for rosacea and to conduct a benefit–cost analysis (BCA) among the Chinese population, so as to provide an economic reference for doctors to make treatment decisions. MATERIALS AND METHODS: An observational, cross-sectional study assessed respondent’s demographic characteristics and willingness-to-pay (WTP) of IPL and rosacea patients’ clinical data and Dermatology Life Quality Index (DLQI). WTP was obtained by contingent valuation (CV) method. In brief, contrast figures of three cases treated with IPL (Case1, Case2, and Case3 represented the increasing severity of rosacea) were showed and WTP was inquired. The costs were obtained according the market and compared with WTP (benefits) to get a benefit–cost ratio (BCR). Predictors of cost-effective WTP were identified using the multivariable logistic regression model. RESULTS: A total of 303 rosacea patients and 202 controls were included in the study. The average cost of a single IPL treatment for rosacea was USD 208.04 in Changsha, China. The mean WTP for Case 1, Case 2, and Case 3 was USD 201.57, 214.64, and 221.74, respectively. WTP was statistically lower for Case 1 than that for Case 2 or Case 3 (P<0.05). The BCRs were 0.85, 1.03, and 1.06 for Case 1, Case 2, and Case 3, respectively. WTP is significantly associated with household monthly income, previous treatment cost, and DLQI after adjustments for demographic characteristics (P<0.05). CONCLUSION: IPL is an acceptable treatment for rosacea with moderate to severe erythema. For patients with relatively high income or severely impaired quality of life, IPL is an economically feasible therapy and deserves to be recommended. Dove 2020-10-09 /pmc/articles/PMC7553264/ /pubmed/33116428 http://dx.doi.org/10.2147/PPA.S271859 Text en © 2020 Deng et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Deng, Qing
Zhang, Shu-ping
Deng, Yu-Xuan
Liu, Fang-fen
Shi, Wei
Xie, Hong-fu
Xiao, Yi
Huang, Ying-Xue
Li, Ji
Willingness-to-Pay and Benefit–Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China
title Willingness-to-Pay and Benefit–Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China
title_full Willingness-to-Pay and Benefit–Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China
title_fullStr Willingness-to-Pay and Benefit–Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China
title_full_unstemmed Willingness-to-Pay and Benefit–Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China
title_short Willingness-to-Pay and Benefit–Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China
title_sort willingness-to-pay and benefit–cost analysis of ipl for rosacea treatment: a cross-sectional study in china
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553264/
https://www.ncbi.nlm.nih.gov/pubmed/33116428
http://dx.doi.org/10.2147/PPA.S271859
work_keys_str_mv AT dengqing willingnesstopayandbenefitcostanalysisofiplforrosaceatreatmentacrosssectionalstudyinchina
AT zhangshuping willingnesstopayandbenefitcostanalysisofiplforrosaceatreatmentacrosssectionalstudyinchina
AT dengyuxuan willingnesstopayandbenefitcostanalysisofiplforrosaceatreatmentacrosssectionalstudyinchina
AT liufangfen willingnesstopayandbenefitcostanalysisofiplforrosaceatreatmentacrosssectionalstudyinchina
AT shiwei willingnesstopayandbenefitcostanalysisofiplforrosaceatreatmentacrosssectionalstudyinchina
AT xiehongfu willingnesstopayandbenefitcostanalysisofiplforrosaceatreatmentacrosssectionalstudyinchina
AT xiaoyi willingnesstopayandbenefitcostanalysisofiplforrosaceatreatmentacrosssectionalstudyinchina
AT huangyingxue willingnesstopayandbenefitcostanalysisofiplforrosaceatreatmentacrosssectionalstudyinchina
AT liji willingnesstopayandbenefitcostanalysisofiplforrosaceatreatmentacrosssectionalstudyinchina